Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
EMCURE
EMCURE

Emcure Pharmaceuticals Ltd.

NSE: EMCURE
BSE: 544210
Sector: Healthcare
Industry: Pharmaceuticals
1,925.80-1.0 (-0.05%)
8 Sep, 12:00 AM

Stock Scores

Quality Score

88.3 / 100

Value Score

33.3 / 100

Price Momentum Score

88.0 / 100

QVM Score

88.7 / 100

Key Metrics

Market Cap
36532.20
P/E (TTM)
36.12
P/B
7.38
P/S (TTM)
3.77
EV/EBITDA
19.99
CAPE (5Y)
55.12
ROE (TTM)
19.68
ROCE (TTM)
22.59
ROA (TTM)
10.36
Avg 3Y ROE
18.79
Earnings 3Y CAGR
20.13
Sales 3Y CAGR
15.42
Sales 5Y CAGR
8.73
Debt/Equity
0.31
Consensus TP
2187.50
Strong Buy %
62.50
Promoter Holding
77.83
Pledged %
0.04

Share Price

Track Emcure Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 4.10 %
Low
1,832.6
High
1,960.1
1 Month returns: -2.84 %
Low
1,829.6
High
2,048.0
1 Year returns: 42.15 %
Low
1,260.0
High
2,048.0
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Emcure Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Emcure Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Emcure Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Emcure Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Emcure Pharmaceuticals Ltd.?
The current share price of Emcure Pharmaceuticals Ltd. is ₹ 1,925.80 as of 8 Sep 2026.
What is the market capitalisation of Emcure Pharmaceuticals Ltd.?
The market capitalisation of Emcure Pharmaceuticals Ltd. stands at ₹ 36,532.20 Cr.
What is the PE ratio of Emcure Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Emcure Pharmaceuticals Ltd. is 36.12 as of the latest trailing twelve months data.
What is the ROE and ROCE of Emcure Pharmaceuticals Ltd.?
Emcure Pharmaceuticals Ltd. has a Return on Equity (ROE) of 19.68% and a Return on Capital Employed (ROCE) of 22.59% as per the latest financial reports.
What is the 52-week high and low of Emcure Pharmaceuticals Ltd.?
The 52-week high of Emcure Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of Emcure Pharmaceuticals Ltd.?
The dividend yield of Emcure Pharmaceuticals Ltd. is 0.16% based on the current market price.
What is the FII and DII holding in Emcure Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 4.87%, Domestic Institutional Investors (DII) hold 8.21% and retail/public investors hold 7.66% of Emcure Pharmaceuticals Ltd. shares.
What sector does Emcure Pharmaceuticals Ltd. belong to?
Emcure Pharmaceuticals Ltd. operates in the Healthcare sector. 87.5% of analysts have a Buy or Strong Buy rating on Emcure Pharmaceuticals Ltd. with a consensus target price of ₹ 2,187.50, implying 13.59% upside from current levels.
What is the beta of Emcure Pharmaceuticals Ltd.?
The beta of Emcure Pharmaceuticals Ltd. is 0.45, indicating its price volatility relative to the broader market. Over the past 1 year, Emcure Pharmaceuticals Ltd. has delivered an absolute return of 41.08%.
What is the RSI of Emcure Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of Emcure Pharmaceuticals Ltd. is 56.98, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.